The overall goal of the Biostatistics and Information Systems Core is to promote scientific rigor in the conduct of all relevant studies and ensure the integrity of results. Members of the Core will assist laboratory and clinical investigators in the design, monitoring, analysis and reporting of findings in an objective manner. They will collaborate with all investigators participating in the program project from the planning stages of each study, clinical and pre-clinical, through its completion. Investigators will receive direct support in the development of research database structures and data management activities to ensure consistency in data collection and facilitate data analysis and reporting of results. The functions of the Core are summarized as follows: 1) provide the required statistical support specific to all scientific investigations, laboratory, preclinical and clinical; 2) develop and maintain databases to handle data collection needs for all studies; 3) oversee and direct data management and data quality control activities across all projects and cores. This Core is a collaboration between Cancer Center Biostatistics and Cancer Center Information Systems (CCIS). Dr. Donna Niedzwiecki, Ph.D., Cancer Center Biostatistics, and Kimberly Johnson, Director of CCIS are Co-Directors of the Core. Dr. Niedzwiecki will direct biostatistics initiatives, while Ms. Johnson will direct information systems initiatives and assist Dr. Niedzwiecki in Core administration. Additional staff includes a staff statistician, a database administrator, a programmer and a data manager. In addition to the core directors, partial support is requested for a staff statistician (.30 FTE total) and two information systems personnel (.35 FTE total) as well as one full-time data manager. The Core will use existing computing infrastructure resources as an efficient means to support funded research. Resources available to this Core include 14 servers supported by CCIS, offering over 6GB of memory and 615 GB of disk space with multi-processing capabilities and a variety of software applications and compilers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA078673-06
Application #
7108680
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
6
Fiscal Year
2005
Total Cost
$126,756
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Aldhamen, Y A; Seregin, S S; Kousa, Y A et al. (2013) Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2. Cancer Gene Ther 20:564-75
Morse, Michael A; Niedzwiecki, Donna; Marshall, John L et al. (2013) A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg 258:879-86
Seregin, Sergey S; Aldhamen, Yasser A; Rastall, David P W et al. (2012) Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine 30:1492-501
Ren, Xiu-Rong; Wei, Junping; Lei, Gangjun et al. (2012) Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells. Breast Cancer Res 14:R89
Osada, Takuya; Morse, Michael A; Hobeika, Amy et al. (2012) Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy. Semin Oncol 39:305-10
Seregin, Sergey S; Amalfitano, Andrea (2011) Gene therapy for lysosomal storage diseases: progress, challenges and future prospects. Curr Pharm Des 17:2558-74
Hartman, Zachary C; Wei, Junping; Glass, Oliver K et al. (2011) Increasing vaccine potency through exosome antigen targeting. Vaccine 29:9361-7
Schuldt, Nathaniel J; Aldhamen, Yasser A; Appledorn, Daniel M et al. (2011) Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses. PLoS One 6:e24147
Seregin, Sergey S; Aldhamen, Yasser A; Appledorn, Daniel M et al. (2011) TRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivo. PLoS One 6:e22064
Osada, Takuya; Chen, Minyong; Yang, Xiao Yi et al. (2011) Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res 71:4172-82

Showing the most recent 10 out of 49 publications